Monotherapy Administration of Sorafenib in Patients with Non-Small Cell Lung Cancer
1 Views
administrator
07/07/23
Vienna, ESMO 2012, Pressconference September 29: Dr Luis Paz-Ares, Oncology Service, Hospital Virgen del Roc, Seville/SPAIN
Monotherapy Administration of Sorafenib in Patients with Non-Small Cell Lung Cancer: Phase III, Randomized, Double-Blind, Placebo-Controlled MISSION Trial.
-
Category
Show more
Facebook Comments
No comments found